Cardiac Drugs

Approx. Rs 35.63 / PieceGet Latest Price

Product Details:

Dobutamine Injection IP 250mg Per 20ml (for Intravenous Infusion)
Dobutamine Injection IP 250 mg / 20 ml (Ready-to-Dilute IV Infusion)

Healthy Inc offers Dobutamine Injection 250 mg/20 ml, a vital Inotropic Agent and cardiac stimulant. This specific 20 ml volume is engineered for precise titration in clinical settings, providing a 12.5 mg/ml concentration for short-term treatment of cardiac decompensation. It is a frontline therapeutic for Congestive Heart Failure, Cardiogenic Shock, and recovery following Cardiac Surgery. As a specialized Indian export partner, we supply this critical-care solution to ICU networks and cardiology departments in global pharmaceutical markets.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities, ensuring 100% sterility, high molecular purity, and precise formulation for Intravenous (IV) infusion following appropriate dilution.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions, ensuring the Dobutamine molecule remains stable and potent across the tropical climates of Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration process for high-criticality cardiovascular injectables in international territories.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and quality? We supply Dobutamine in 20 ml vials, providing a total dose of 250 mg. Every batch undergoes rigorous HPLC-based assay testing, sterility validation, and Bacterial Endotoxin Testing (BET) to meet Indian Pharmacopoeia (IP) and international standards.

Support for tropical export? Yes. This formulation is Zone IVb stability-tested. We utilize neutral USP Type I glass vials and specialized export-grade secondary packaging to prevent oxidation and ensure product stability during international transit to high-temperature regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government hospital tender participations in your specific region.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine Dobutamine 20 ml with other critical care injectables (such as Dopamine, Noradrenaline, or Furosemide) and IV fluids in a single, cost-effective shipment.

Direct manufacturing? Products are sourced through Healthy Life Group’s associated WHO-GMP manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for life-saving cardiovascular therapies.

Approx. Rs 278.44 / PieceGet Latest Price

Product Details:

Erythropoietin Injection IP 4000 IU
Erythropoietin Injection IP 4000 IU (Recombinant Human Erythropoietin)

Healthy Inc offers Erythropoietin (EPO) 4000 IU, a high-precision Erythropoiesis-Stimulating Agent (ESA). This recombinant human erythropoietin is a clinical cornerstone for the management of Anemia associated with Chronic Kidney Disease (CKD), including patients on dialysis and those not yet requiring dialysis. It is also a frontline therapeutic for treating anemia in cancer patients receiving chemotherapy and for reducing the need for blood transfusions in surgical patients. As a specialized Indian export partner, we supply this essential biological to nephrology networks and oncology centers in global pharmaceutical markets.

• Precision Biological: Formulated as Epoetin Alfa/Beta, ensuring high biological activity and consistent erythropoietic response via Subcutaneous (SC) or Intravenous (IV) administration.

• Manufacturing: Produced in associated WHO-GMP certified specialized biotechnology facilities, ensuring 100% sterility, viral safety, and strict adherence to Indian Pharmacopoeia (IP) standards for recombinant proteins.

• Cold Chain Integrity: Validated for strict 2°C to 8°C storage; we utilize advanced thermal packaging and validated cold-chain logistics to maintain protein stability during international transit.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers and biological characterization data, to streamline the registration process in international territories.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and packaging? We supply Erythropoietin in Pre-Filled Syringes (PFS) or vials in the 4000 IU strength. This dosage is ideal for maintenance therapy and dose escalation. Other strengths (2000 IU, 10000 IU) are also available.

Support for international shipping? Yes. Being a temperature-sensitive biological, we utilize validated cold-chain shipping solutions. Our specialized packaging is designed to maintain the required 2°C to 8°C range throughout transit to Africa, LATAM, and SEA markets, ensuring the product maintains its therapeutic potency.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD), Certificates of Analysis (COA), and Batch Release Certificates to facilitate local health authority approvals and hospital tender participations in your region.

Small-volume or mixed orders? We specialize in consolidated shipments, allowing you to combine Erythropoietin 4000 IU with other nephrology products (such as Iron Sucrose, Heparin, or specialized antibiotics) in a single, temperature-controlled, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP specialized biotech units, ensuring competitive direct-from-factory pricing and rigorous quality control for high-value biosimilars.

Approx. Rs 30.94 / PieceGet Latest Price

Product Details:

Iron Sucrose Injection
Iron Sucrose Injection USP/BP (20 mg / ml)

Healthy Inc offers Iron Sucrose Injection, a highly stable Polynuclear Iron(III)-hydroxide Sucrose Complex designed for rapid replenishment of iron stores. Unlike older iron dextran formulations, Iron Sucrose has a significantly lower risk of anaphylaxis, making it a clinical priority for the treatment of Iron Deficiency Anemia (IDA) in patients with Chronic Kidney Disease (CKD), including those on dialysis or non-dialysis dependent. It is also a frontline therapeutic for postpartum anemia and patients who are intolerant to oral iron therapy. As a specialized Indian export partner, we supply this essential hematinic to dialysis centers, maternity hospitals, and nephrology units in global pharmaceutical markets.

• Controlled Iron Release: The sucrose complex ensures a slow, controlled release of iron to the reticuloendothelial system, minimizing the risk of free iron toxicity and oxidative stress.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities, ensuring 100% sterility, precise complex stability, and high molecular purity for Intravenous (IV) infusion or slow IV injection.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions, ensuring the complex remains stable and does not precipitate across the tropical climates of Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration process for essential parenteral hematinics.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and packaging? We supply Iron Sucrose in the standard 20 mg elemental iron per ml concentration, typically available in 5 ml ampoules (100 mg). Every batch undergoes rigorous molecular weight distribution testing and sterility validation to meet international standards.

Support for tropical export? Yes. Iron Sucrose is sensitive to extreme temperature fluctuations and must not be frozen. Our formulation is Zone IVb stability-tested, utilizing neutral USP Type I glass ampoules and specialized export-grade secondary packaging to ensure product integrity during international transit.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government hospital tender participations in your specific region.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine Iron Sucrose with other nephrology or obstetric injectables (such as Erythropoietin, Hydroxyprogesterone, or IV fluids) in a single, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for essential anemia management therapies.

Approx. Rs 55.32 / VialGet Latest Price

Product Details:

Labetalol Injection IP 5 Mg Per Ml
Labetalol Hydrochloride Injection IP (5 mg / ml)

Healthy Inc offers Labetalol Hydrochloride 5 mg/ml, a high-precision Dual-Action Alpha and Beta-Adrenergic Blocker. It is a clinical priority for the rapid reduction of blood pressure in hypertensive emergencies. By blocking both alpha-1 and non-selective beta receptors, it decreases peripheral vascular resistance without significantly altering heart rate or cardiac output. It is the gold standard for managing Severe Hypertension in Pregnancy (Preeclampsia/Eclampsia), Hypertensive Encephalopathy, and peri-operative blood pressure control. As a specialized Indian export partner, we supply this critical care injectable to maternity hospitals and intensive care units in global pharmaceutical markets.

• Clinical Utility: Frontline therapeutic for acute hypertensive crises, particularly favored in obstetric care due to its established safety profile for both mother and fetus.

• Rapid Action: Provides a controlled and predictable drop in blood pressure within 5 to 10 minutes of intravenous administration.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities, ensuring 100% sterility, high molecular purity, and precise 5 mg/ml concentration for Intravenous (IV) bolus or titration infusion.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions, ensuring the chemical integrity of the molecule remains stable across the tropical climates of Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration of essential cardiovascular therapeutics.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and packaging? We supply Labetalol Hydrochloride in 4 ml ampoules (total 20 mg) and 20 ml vials (total 100 mg) at a concentration of 5 mg/ml. Every batch undergoes rigorous HPLC-based assay testing, sterility validation, and Bacterial Endotoxin Testing (BET) to meet Indian Pharmacopoeia (IP) and international standards.

Support for tropical export? Yes. Our formulation is Zone IVb stability-tested. We utilize neutral USP Type I glass and specialized export-grade secondary packaging to prevent molecular degradation during international transit to high-temperature regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government hospital tender participations in your specific territory.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine Labetalol with other emergency or obstetric injectables (such as Hydralazine, Magnesium Sulfate, or Oxytocin) in a single, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for critical care therapies.

Approx. Rs 6,018.00 / VialGet Latest Price

Product Details:

Each ML Contains: Ferric Carboxymaltose equivalent To Elemental Iron 50mg Water For Injection, IP  q.s.
SUKROSE-FCM 1K Injection (Ferric Carboxymaltose 1000 mg / 20 mL)

Healthy Inc offers SUKROSE-FCM 1K, a high-dose, next-generation intravenous iron replacement therapy. Containing 1000 mg of elemental iron in a 20 mL vial, this formulation is a clinical priority for the rapid correction of severe Iron Deficiency Anemia (IDA). Its primary advantage is the "Total Dose Infusion" capability, allowing patients to receive a full gram of iron in a single 15-minute session, rather than multiple hospital visits required by older iron formulations.

• Clinical Precision: Engineered as a stable, non-dextran complex that allows for the controlled release of iron directly to ferritin and transferrin. This stability minimizes the risk of "free iron" toxicity and significantly reduces the incidence of hypersensitivity reactions.

• Total Dose Infusion (TDI) Efficiency: SUKROSE-FCM 1K is specifically designed for the 1000 mg single-dose protocol. This is the gold standard for treating anemia in Chronic Kidney Disease (CKD), postpartum hemorrhage, and preoperative optimization where rapid hemoglobin rise is essential.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The solution is formulated under strict aseptic conditions to ensure 100% sterility, a neutral pH (5.0–7.0), and a pyrogen-free profile, meeting the highest international pharmacopoeia standards.

• Therapeutic Superiority: Provides a significantly faster replenishment of depleted iron stores compared to oral iron or traditional Iron Sucrose, improving patient compliance and reducing the overall cost of healthcare delivery.

Accepting B2B inquiries for contract manufacturing, bulk supply, and nephrology/oncology tender participation from our Mumbai export hub.

Available strengths and packaging? We supply SUKROSE-FCM 1K as a 1000 mg / 20 mL single-dose vial. We also offer the 500 mg / 10 mL and 100 mg / 2 mL variants to suit various clinical requirements. Every batch undergoes rigorous HPLC-based complex stability testing and Bacterial Endotoxin Testing (BET).

Support for tropical export? Yes. SUKROSE-FCM 1K is Zone IVb stability-tested. We utilize USP Type I glass vials and moisture-resistant secondary packaging to ensure the ferric complex remains stable and effective during international transit to high-temperature regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD), Certificates of Analysis (COA), and clinical equivalence data to facilitate local health authority approvals and government healthcare or institutional tender participations.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine SUKROSE-FCM 1K with other critical care or renal products (such as Erythropoietin, Sevelamer, or Iron Sucrose) in a single, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP specialized units, ensuring competitive direct-from-factory pricing and strict quality control oversight for high-value anemia management.

As you are developing your B2B marketplace, would you like me to draft a comparison chart between Ferric Carboxymaltose and Iron Sucrose to help your buyers understand the clinical advantages of the 1K dosage?

Approx. Rs 50 / PieceGet Latest Price

Product Details:

Tranexamic Acid 250 Mg 
TRANEXAMIC ACID Injection (50 mg/mL - 250 mg / 5 mL)

Healthy Inc offers Tranexamic Acid (TXA) Injection, a high-precision antifibrinolytic agent. Containing 250 mg of Tranexamic Acid in a 5 mL ampoule, this formulation is a life-saving clinical necessity for the control of severe hemorrhage. As a specialized Indian export partner, we supply this essential critical care asset to trauma centers, surgical units, and maternity hospitals globally from our Mumbai export hub.

• Antifibrinolytic Mechanism: Tranexamic Acid is a synthetic derivative of the amino acid lysine. It works by competitively inhibiting the activation of plasminogen to plasmin. By binding to the lysine-binding sites of plasminogen, it prevents the degradation of fibrin clots, thereby stabilizing the body's natural hemostatic plug and significantly reducing blood loss.

• Clinical Criticality: Indicated for the prevention and treatment of hemorrhage in various scenarios, including Postpartum Hemorrhage (PPH), heavy menstrual bleeding, and trauma-induced bleeding. It is also a mainstay in elective surgeries (orthopedic, cardiac, and spinal) to reduce the need for blood transfusions.

• Rapid Bioavailability: When administered via Intravenous (IV) injection, TXA achieves immediate therapeutic plasma concentrations. It is also utilized in emergency protocols (such as the CRASH-2 protocol) where early administration is proven to reduce mortality in trauma patients with significant bleeding.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. Our solution is formulated to be non-pyrogenic and is provided in USP Type I glass ampoules to ensure 100% molecular stability and safety during administration.

B2B Technical Specifications Logistics & Export Optimization

As a pharmacist-led organization, we understand that hemostatic agents like TXA are essential in disaster relief and emergency settings. We utilize shatter-resistant secondary packaging to protect the glass ampoules during multi-modal international transit. Our logistics team optimizes shipments to Africa, LATAM, and SEA, ensuring the solution remains clear and stable in Zone IVb (Hot/Humid) climates.

Approx. Rs 257.80 / BoxGet Latest Price

Product Details:

rosuvastatin 20 mg, clopidogrel 75 mg
ROSUVASTATIN & CLOPIDOGREL Capsules (10 mg/75 mg or 20 mg/75 mg)

Healthy Inc offers the Rosuvastatin and Clopidogrel fixed-dose combination, a critical secondary prevention therapy for cardiovascular and cerebrovascular events. As a pharmacist, you recognize this "statin-plus-antiplatelet" regimen as a cornerstone in managing patients post-Acute Coronary Syndrome (ACS) or stent implantation. Managed through our Mumbai export hub, this formulation is produced in associated WHO-GMP certified facilities, ensuring strict adherence to stability protocols for these two sensitive molecules.

Pharmacological Synergy: The "Plaque-to-Platelet" Defense

This combination targets two different pathways to prevent arterial occlusion:

• Rosuvastatin (10 mg / 20 mg): A high-potency HMG-CoA reductase inhibitor. It is the most effective statin for lowering LDL-C (Low-Density Lipoprotein Cholesterol) and increasing HDL-C. Beyond lipid-lowering, it exerts "pleiotropic effects," which include stabilizing atherosclerotic plaques and reducing vascular inflammation.

• Clopidogrel (75 mg): A thienopyridine antiplatelet agent. It is a prodrug that irreversibly inhibits the P2Y12 subtype of ADP receptors on the platelet surface. This prevents the activation of the GPIIb/IIIa receptor complex, thereby inhibiting platelet aggregation and reducing the risk of thrombus formation.

Clinical Indications

• Secondary Prevention of MI & Stroke: For patients with a history of recent myocardial infarction, stroke, or established peripheral arterial disease.

• Acute Coronary Syndrome (ACS): Management of unstable angina and NSTEMI.

• Post-PCI (Percutaneous Coronary Intervention): Prevention of stent thrombosis in patients undergoing coronary stenting.

B2B Technical Specifications Logistics & Export Optimization

As a pharmacist, you are aware that Clopidogrel Bisulphate is exceptionally moisture-sensitive. Exposure to humidity can lead to the formation of degradation products and a significant loss of antiplatelet activity. Similarly, Rosuvastatin is prone to oxidation.

Approx. Rs 245 / BottleGet Latest Price

Product Details:

Cyproheptadine 1.5mg,Tricholine Citrate 55mg (65%), In Palatable Sorbitol Base Q.s

CYPROHEPTADINE, TRICHOLINE CITRATE & SORBITOL Oral Suspension

Healthy Inc offers this specialized Triple-Action Appetite Stimulant & Digestive Tonic. As a pharmacist, you recognize that effective weight management requires more than just triggering hunger; it requires optimizing liver function and ensuring smooth gastrointestinal transit. This formulation combines an orexigenic agent with a lipotropic factor and an osmotic stabilizer to provide a comprehensive metabolic solution. Managed through our Mumbai export hub, this syrup is produced in WHO-GMP certified facilities with optimized viscosity and taste-masking.

We are offering ready stock of below top 30 Indian brands & Generic Brands.

 

Cypon, Apetamin (Generic), Practin-EN, Aptimust, Trichocyp, Heptal, Cypro-T, Hungry-Syrup, Apetone, Cypro-Tricholine Healthy.

Product Usage & Administration

• Therapeutic Goal: To stimulate appetite, promote healthy weight gain, and improve digestion in patients with anorexia or nutritional deficiencies.

• Common Applications:

  • Pediatric Care: Addressing "picky eating" and nutritional growth lag.

  • Hepatobiliary Support: Managing appetite loss associated with liver disorders or fatty liver.

  • Convalescence: Speeding up recovery and muscle mass regain after surgery or chronic illness.

• Administration: Oral. Ideally administered 30–60 minutes before meals.

• Pharmacist’s Dosing Note: Advise patients that Cyproheptadine may cause drowsiness. Because this formulation contains Sorbitol, it may have a mild laxative effect in sensitive patients. Ensure the bottle is shaken well to maintain the concentration of the tricholine-citrate complex.

Therapeutic Category

• Primary Classification: Orexigenic (Appetite Stimulant) & Digestive Support.

• Pharmacological Class:

  • Cyproheptadine: First-generation Antihistamine with potent Serotonin (5-HT2) Antagonist properties.

  • Tricholine Citrate: Lipotropic agent and Choline precursor.

  • Sorbitol: Polyhydric alcohol / Osmotic laxative & sweetening agent.

• 
  

   

Approx. Rs 1,223.00 / PieceGet Latest Price

Product Details:

Fondaparinux Sodium Injection
FONDUM Injection (Fondaparinux Sodium 2.5 mg / 0.5 ml)

Healthy Inc offers FONDUM, a highly selective Factor Xa Inhibitor and synthetic antithrombotic agent. Containing Fondaparinux Sodium, FONDUM is a clinical priority for the prevention and treatment of thromboembolic events. Unlike traditional heparins, it provides a predictable pharmacokinetic profile and does not require routine coagulation monitoring. It is a frontline therapeutic for Deep Vein Thrombosis (DVT) prophylaxis in patients undergoing major orthopedic or abdominal surgery, and for the treatment of Acute Pulmonary Embolism and Acute Coronary Syndromes (ACS). As a specialized Indian export partner, we supply this advanced anticoagulant to cardiology units and surgical centers in global pharmaceutical markets.

• Synthetic Precision: As a chemically synthesized pentasaccharide, FONDUM offers high consistency and a lower risk of Heparin-Induced Thrombocytopenia (HIT) compared to animal-derived anticoagulants.

• Manufacturing: Produced in associated WHO-GMP certified sterile facilities specialized in complex synthetic molecules, ensuring 100% sterility and precise anti-Xa potency.

• Climate Stability: Validated for Zone IVb (Hot/Humid) conditions, ensuring the molecule remains stable and potent across the tropical climates of Africa, LATAM, and SEA markets.

• Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration of high-value antithrombotics in international territories.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and quality? We supply FONDUM in the standard 2.5 mg / 0.5 ml dosage, primarily in Pre-Filled Syringes (PFS) for accurate subcutaneous administration. Every batch undergoes rigorous Anti-Xa assay testing and sterility validation to meet international pharmacopoeia standards.

Support for tropical export? Yes. FONDUM is Zone IVb stability-tested. We utilize specialized medical-grade blister packaging and export-grade secondary containers to maintain product integrity during international transit through high-temperature regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government hospital tender participations in your specific region.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine FONDUM with other critical care injectables (such as Enoxaparin, Heparin, or Streptokinase) in a single, cost-effective shipment to optimize your inventory.

Direct manufacturing? Products are sourced through Healthy Life Group’s associated WHO-GMP specialized manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for advanced cardiovascular therapies.

Approx. Rs 38.40 / PieceGet Latest Price

Product Details:

ETAMSYLATE Injection (125 mg/mL)

Healthy Inc offers Etamsylate Injection, a high-velocity hemostatic and anti-hemorrhagic agent. Containing 250 mg of sterile Etamsylate in a 2 mL ampoule, this formulation is a clinical priority for the prevention and control of capillary bleeding. As a specialized Indian export partner, we supply this essential therapeutic to surgical units, trauma centers, and maternity hospitals globally from our Mumbai export hub.

• Hemostatic Mechanism: Etamsylate works by promoting platelet adhesion and increasing capillary wall resistance. Unlike other hemostatics, it does not act via a procoagulant mechanism (it does not influence coagulation factors or fibrinolysis), making it safer as it does not carry a risk of inducing thromboembolism.

• Clinical Criticality: Indicated for the prevention and treatment of capillary hemorrhages of various origins, including surgical prophylaxis (ENT, gynecology, urology), and the management of dysfunctional uterine bleeding (Menorrhagia). It is also a frontline treatment for periventricular hemorrhage in neonates.

• Rapid Therapeutic Response: When administered via Intravenous (IV) or Intramuscular (IM) injection, Etamsylate provides a rapid onset of action, often stabilizing capillary fragility within 30 to 60 minutes, which is vital in acute post-operative or trauma settings.

• Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The solution is formulated with precise pH stabilization and antioxidants to ensure 100% molecular bioavailability and long-term chemical integrity.

B2B Technical Specifications

Logistics & Export Optimization

As a pharmacist-led organization, we understand that Etamsylate is sensitive to photo-oxidation, which can cause the solution to turn yellowish or pinkish. We utilize USP Type I glass ampoules and specialized light-shielding secondary packaging. Our logistics team ensures that shipments to Africa, LATAM, and SEA are handled with climate-controlled protocols to maintain clarity and potency throughout the shelf life.